CEST (Brussels time)
90 minutes
HP6
Treating carious lesions traditionally requires restorative procedures that may compromise healthy tooth structure. Consider a ground-breaking, innovative approach that arrests and reverses incipient carious lesions through Guided Enamel Regeneration. Clinically proven biomimetic peptide technology now offers a revolutionary solution for managing early carious lesions (also referred to as "Watch Areas") by regenerating the enamel. This non-invasive, precise, pain-free, and conservative treatment option with a promising success rate above 90%, enhances both patient experience and clinical efficiency.
AI software facilitates detection of incipient lesions from bitewing radiographs that often go undetected, increasing practitioners’ diagnostic accuracy and providing effective patient communication. Once these lesions are detected in their initial stages, treating them with novel biomimetic peptide technology marks a significant advancement in the dental field, effectively turning back the clock on carious progression.
By completing this session delegates will gain insight into:
- Non-Invasive management of early carious lesions through Guided Enamel Regeneration.
- Diagnostic options for early carious lesions.
- What is Biomimetic Peptide Technology-the science, overview, and mode of action.
- The revolutionary non-invasive approach to arrest incipient lesions in their early stages.
- Clinical application and workflow.
